Early Fall in C-Reactive Protein (CRP) Level Predicts Response to Tocilizumab in Rapidly Progressing COVID-19: Experience in a Single-Arm Pakistani Center-Reference-Cited by-同舟云学术

Early Fall in C-Reactive Protein (CRP) Level Predicts Response to Tocilizumab in Rapidly Progressing COVID-19: Experience in a Single-Arm Pakistani Center

Published:2021-11-30 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Khurshid Saba,Rehman Neelum,Ahmed Saad,Ahmad Bilal,Khurshid Mustafa,Muhammad Anjum,Siddiqi Fuad A,Nayab Dure,Saleem Hasan,Saleem Zulqurnain

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference29 articles.

1. Elevated interleukin-6 and severe COVID-19: a meta-analysis;Aziz M;J Med Virol,2020

2. Risk factors of severe cases with COVID-19: a meta-analysis;Ou M;Epidemiol Infect,2020

3. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial;Perrone F;J Transl Med,2020

4. Tocilizumab treatment in COVID-19: a single center experience;Luo P;J Med Virol,2020

5. Appropriate use of tocilizumab in COVID-19 infection;Keske Ş;Int J Infect Dis,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tocilizumab demonstrates superiority in decreasing C-reactive protein levels in hospitalized COVID-19 patients, compared to standard care treatment alone;Microbiology Spectrum;2024-06-04

2. Effect of Tocilizumab on Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta or Omicron Variants: A Propensity-Matched Analysis in Nimes University Hospital, France;Antibiotics;2023-01-04

3. C-Reactive Protein (CRP): A poor prognostic biomarker in COVID-19;Frontiers in Immunology;2022-11-14

4. Predictors of the Outcomes Following the Tocilizumab Treatment for Severe COVID-19;Cureus;2022-08-26